Linden Thomas Advisory Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,918
| Closed | -$246K | – | 470 |
|
|
2024
Q4 | $246K | Buy |
5,918
+6
| +0.1% | +$249 | 0.03% | 443 |
|
|
2024
Q3 | $395K | Buy |
5,912
+317
| +6% | +$21.2K | 0.05% | 396 |
|
|
2024
Q2 | $664K | Buy |
5,595
+79
| +1% | +$9.38K | 0.1% | 318 |
|
|
2024
Q1 | $588K | Buy |
5,516
+443
| +9% | +$47.2K | 0.09% | 330 |
|
|
2023
Q4 | $505K | Buy |
5,073
+256
| +5% | +$25.5K | 0.09% | 332 |
|
|
2023
Q3 | $498K | Sell |
4,817
-4,938
| -51% | -$510K | 0.11% | 324 |
|
|
2023
Q2 | $1.19M | Buy |
9,755
+264
| +3% | +$32.1K | 0.26% | 157 |
|
|
2023
Q1 | $1.46M | Buy |
9,491
+213
| +2% | +$32.7K | 0.36% | 103 |
|
|
2022
Q4 | $1.67M | Buy |
+9,278
| New | +$1.67M | 0.47% | 59 |
|